Through the acquisition, BD — a medical equipment supplier — will expand its portfolio to include vascular, urology, oncology and surgical specialty products.
Both companies’ boards unanimously approved the agreement, and the deal is expected to close in fall 2017.
More articles on supply chain:
FDA finalizes decision to keep impounded execution drugs from Texas justice system
Sanofi epilepsy drug linked to birth deformities
Marathon 2nd drugmaker to resign from PhRMA this month
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
